Head-to-Head trial tests which pill works better for common liver condition
NCT ID NCT05042245
Summary
This study compared two existing oral medications—ornithine aspartate granules and silymarin capsules—to see which is more effective at treating non-alcoholic fatty liver disease (NAFLD). It involved 237 adults with confirmed NAFLD and elevated liver enzymes. The main goal was to see which treatment better reduced liver fat and improved patients' quality of life over the course of the trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC FATTY LIVER DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200092, China
Conditions
Explore the condition pages connected to this study.